Subclinical atherosclerosis in multiple sclerosis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Multiple sclerosis (MS) patients do not show increased subclinical atherosclerosis compared to those without MS. The Framingham Score effectively predicted atherosclerosis risk in both groups, indicating MS itself is not a direct risk factor for this arterial disease.
Area Of Science
- Cardiovascular Health
- Neurology
- Immunology
Background
- Multiple sclerosis (MS) is linked to a higher risk of ischemic heart disease.
- Traditional vascular risk factors do not fully explain this increased cardiovascular risk in MS patients.
Purpose Of The Study
- To investigate subclinical atherosclerosis in individuals with MS lacking traditional vascular risk factors.
- To determine if the Framingham Score (FRS) predicts carotid intima-media thickness (CIMT) similarly in people with and without MS.
Main Methods
- Recruited participants with and without MS, excluding those with existing vascular disease.
- Assessed subclinical atherosclerosis using carotid intima-media thickness (CIMT) ultrasound and defined it as CIMT ≥75th percentile.
- Utilized logistic regression to analyze the association between MS, FRS, and atherosclerosis.
Main Results
- No significant difference in average CIMT or the prevalence of subclinical atherosclerosis was found between MS and non-MS cohorts.
- A 1-point increase in FRS was associated with an 11% increased odds of atherosclerosis.
- Multiple sclerosis status was not independently associated with subclinical atherosclerosis.
Conclusions
- Subclinical atherosclerosis is not more prevalent in individuals with MS compared to those without MS.
- The Framingham Score remains a relevant predictor of atherosclerosis, independent of MS status.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
